Product Program year 2025 Source: CMS Open Payments

t:slim X2 Insulin Pump with Control-IQ

Device Endocrinology

PDI 00850006613229

Open in the dashboard

General payments

$5,076,521

36,560 payments

Research payments

$8,817,385

114 payments

Through program year 2025, $5,076,521 in general payments and $8,817,385 in research payments were reported against t:slim X2 Insulin Pump with Control-IQ (Endocrinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $1,517,063 13,278
2025 Research $1,168,819 7
2024 General $1,383,014 9,526
2024 Research $4,699,226 33
2023 General $1,031,210 7,559
2023 Research $2,058,777 53
2022 General $1,145,233 6,197
2022 Research $890,563 21

Breakdown

Who paid General payments · program years 2022–2025
  1. Tandem Diabetes Care, Inc. $5,076,521 36,560 payments
Top recipients General payments · program year 2025
  1. Ohsu Hospital And Clinics Teaching hospital · OR $55,234 4% · 40 payments
  2. Childrens Hospital Medical Center Teaching hospital · OH $46,650 3% · 37 payments
  3. Cleveland Clinic Hospital Teaching hospital · OH $39,300 3% · 43 payments
  4. Deaconess Medical Center Teaching hospital · WA $34,500 2% · 63 payments
  5. The Childrens Hospital Of Philadelp Teaching hospital · PA $31,275 2% · 40 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $276,881 39% · 1,870 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $96,674 13% · 903 practitioners
  3. Nurse Practitioner $96,186 13% · 383 practitioners
  4. Pediatric Endocrinology Pediatrics $47,041 7% · 249 practitioners
  5. Internal Medicine $39,855 6% · 285 practitioners

The top 5 of 113 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $159,809 11% · 223 recipients
  2. Michigan $147,225 10% · 114 recipients
  3. Pennsylvania $110,168 7% · 258 recipients
  4. Washington $90,724 6% · 96 recipients
  5. Oregon $75,798 5% · 57 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

36,560 general · 114 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record